Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01296477 · ClinicalTrials.gov registry record
To Evaluate the Use of ASTHMA IQ in a Primary Care Setting
A clinical trial, sponsored by American Academy of Family Physicians.
- Completed
- Registry status
- 375
- Enrollment target
NCT01296477 is a clinical trial that has completed, run by American Academy of Family Physicians. The registered enrollment target is 375 participants.
The verdict
NCT01296477 has completed, sponsored by American Academy of Family Physicians.
- COMPLETED
- Registry status
- 375 participants
- Enrollment target
Study Summary
There is a mounting body of evidence suggesting that there is a large disparity between the development and the actual implementation of guideline-driven asthma care in primary and specialty care practices. To address this disparity, the American Academy of Allergy, Asthma \& Immunology (AAAAI) developed a unique, comprehensive and easy-to-use Web-based tool for clinicians who treat asthma patients called "Asthma Specialist Tool to Help Manage Asthma and Improve Quality" (Asthma-IQ). This study will examine whether the use of the Asthma IQ primary care tool will improve asthma care and asthma outcomes using a randomized trial of the Asthma IQ system versus usual asthma care in the primary care setting over 1 year. At the end of 1 year, all patients will be managed using the Asthma-IQ tool for an additional year to determine if the patients managed by usual care in the first year improve when managed in conjunction with Asthma-IQ. The primary endpoint to determine if the use of the Asthma IQ tool will improve asthma patient outcomes is quarterly assessments of Asthma Control Test (ACT) scores via automated / electronic patient survey. The secondary endpoint is asthma exacerbations and there are a number of exploratory endpoints to further define the clinical utility of the primary care version of Asthma-IQ. This study will involve recruiting approximately 20 family medicine offices with approximately 20 patients each, to conduct this randomized, multiple time point intervention trial. The necessary total recruited patient sample size is 200 per group. The results of this study will help determine the utility of Web-based tools to help manage chronic diseases such as asthma.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375 participants |
| Start Date | 2010-12 |
| Est. Completion | 2015-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01296477
The ClinicalTrials.gov registry entry for NCT01296477 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 375 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American Academy of Family Physicians, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01296477 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01296477 about?
NCT01296477 is a clinical study titled "To Evaluate the Use of ASTHMA IQ in a Primary Care Setting". There is a mounting body of evidence suggesting that there is a large disparity between the development and the actual implementation of guideline-driven asthma care in primary and specialty care practices. To address this disparity, the American Academy of Allergy, Asthma \& Immunology (AAAAI) deve...
What is the current status of trial NCT01296477?
This trial is currently completed. The enrollment target is 375 participants. The study started on 2010-12. Estimated completion is 2015-09.
Who is sponsoring clinical trial NCT01296477?
This trial is sponsored by American Academy of Family Physicians, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.